Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2356991
Max Phase: Preclinical
Molecular Formula: C36H52ClN3O5Si
Molecular Weight: 670.37
Molecule Type: Small molecule
Associated Items:
ID: ALA2356991
Max Phase: Preclinical
Molecular Formula: C36H52ClN3O5Si
Molecular Weight: 670.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CN([C@H](C)CO[Si](C)(C)C(C)(C)C)C(=O)c2cc(NC(=O)C3CCCCC3)ccc2O[C@H]1CN(C)C(=O)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C36H52ClN3O5Si/c1-24-21-40(25(2)23-44-46(7,8)36(3,4)5)35(43)30-20-29(38-33(41)26-12-10-9-11-13-26)18-19-31(30)45-32(24)22-39(6)34(42)27-14-16-28(37)17-15-27/h14-20,24-26,32H,9-13,21-23H2,1-8H3,(H,38,41)/t24-,25-,32+/m1/s1
Standard InChI Key: QYVQBRFDXPCDST-VJQVOXFUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 670.37 | Molecular Weight (Monoisotopic): 669.3365 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. PubChem BioAssay data set, |
Source(1):